| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥1.90T | ¥1.82T | +4.0% |
| Cost of Sales | ¥1.77T | ¥1.70T | +4.1% |
| Gross Profit | ¥130.28B | ¥126.44B | +3.0% |
| SG&A Expenses | ¥105.20B | ¥99.28B | +6.0% |
| Operating Income | ¥25.08B | ¥27.16B | -7.7% |
| Non-operating Income | ¥10.95B | ¥8.91B | +22.9% |
| Non-operating Expenses | ¥1.76B | ¥991M | +77.8% |
| Ordinary Income | ¥34.27B | ¥35.08B | -2.3% |
| Profit Before Tax | ¥39.81B | ¥39.77B | +0.1% |
| Income Tax Expense | ¥12.32B | ¥12.20B | +1.0% |
| Net Income | ¥27.48B | ¥27.57B | -0.3% |
| Net Income Attributable to Owners | ¥22.09B | ¥21.73B | +1.7% |
| Total Comprehensive Income | ¥25.04B | ¥35.27B | -29.0% |
| Depreciation & Amortization | ¥8.58B | ¥8.51B | +0.8% |
| Interest Expense | ¥6M | ¥3M | +100.0% |
| Basic EPS | ¥106.80 | ¥103.94 | +2.8% |
| Dividend Per Share | ¥30.00 | ¥30.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥1.37T | ¥1.28T | +¥86.41B |
| Cash and Deposits | ¥276.63B | ¥261.41B | +¥15.23B |
| Accounts Receivable | ¥816.30B | ¥763.54B | +¥52.76B |
| Inventories | ¥190.50B | ¥178.10B | +¥12.40B |
| Non-current Assets | ¥538.46B | ¥542.24B | ¥-3.77B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥25.50B | ¥41.83B | ¥-16.33B |
| Investing Cash Flow | ¥5.28B | ¥-6.52B | +¥11.80B |
| Financing Cash Flow | ¥-15.96B | ¥-14.38B | ¥-1.59B |
| Free Cash Flow | ¥30.78B | - | - |
| Item | Value |
|---|---|
| Book Value Per Share | ¥3,037.32 |
| Net Profit Margin | 1.2% |
| Gross Profit Margin | 6.9% |
| Current Ratio | 125.8% |
| Quick Ratio | 108.3% |
| Debt-to-Equity Ratio | 1.49x |
| Interest Coverage Ratio | 4180.50x |
| EBITDA Margin | 1.8% |
| Effective Tax Rate | 31.0% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +4.0% |
| Operating Income YoY Change | -7.7% |
| Ordinary Income YoY Change | -2.3% |
| Net Income Attributable to Owners YoY Change | +1.7% |
| Total Comprehensive Income YoY Change | -29.0% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 219.23M shares |
| Treasury Stock | 13.89M shares |
| Average Shares Outstanding | 206.84M shares |
| Book Value Per Share | ¥3,731.09 |
| EBITDA | ¥33.66B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥30.00 |
| Year-End Dividend | ¥32.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| AnimalHealthProductsAndFoodProcessingRawMaterialsWholesaleAndRelated | ¥58.61B | ¥1.35B |
| CosmeticsDailyNecessitiesAndOTCPharmaceuticalWholesale | ¥625.13B | ¥13.89B |
| PrescriptionPharmaceuticalWholesale | ¥1.22T | ¥9.67B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥3.79T |
| Operating Income Forecast | ¥52.00B |
| Ordinary Income Forecast | ¥69.00B |
| Net Income Attributable to Owners Forecast | ¥34.50B |
| Basic EPS Forecast | ¥167.28 |
| Dividend Per Share Forecast | ¥32.00 |
| Property, Plant & Equipment | ¥265.31B | ¥268.56B | ¥-3.25B |
| Intangible Assets | ¥38.22B | ¥39.90B | ¥-1.68B |
| Goodwill | ¥12.53B | ¥13.15B | ¥-625M |
| Investment Securities | ¥194.74B | ¥199.08B | ¥-4.34B |
| Total Assets | ¥1.91T | ¥1.82T | +¥82.64B |
| Current Liabilities | ¥1.09T | ¥1.01T | +¥78.53B |
| Accounts Payable | ¥1.00T | ¥932.47B | +¥69.76B |
| Non-current Liabilities | ¥53.51B | ¥57.59B | ¥-4.08B |
| Total Liabilities | ¥1.14T | ¥1.07T | +¥74.45B |
| Total Equity | ¥766.14B | ¥757.95B | +¥8.19B |
| Capital Stock | ¥22.40B | ¥22.40B | ¥0 |
| Capital Surplus | ¥100.02B | ¥100.01B | +¥10M |
| Retained Earnings | ¥477.28B | ¥463.07B | +¥14.21B |
| Treasury Stock | ¥-28.57B | ¥-22.19B | ¥-6.38B |
| Owners' Equity | ¥623.68B | ¥619.56B | +¥4.12B |
| Working Capital | ¥281.18B | - | - |